Clearly, integrating gene transfer vectors have been associated with potentially dangerous genetic lesions.
HSV-TK vectors have been successfully employed in cardiovascular and cancer gene therapy.
Word feature vectors have been proven to improve many natural language processing tasks.
In order to circumvent this limitation, nonhuman adenoviral vectors have been proposed as alternative vectors.
Moreover, vectors have been engineered to blend RNAi-mediated gene inhibition with conventional gene replacement strategies.
Few integrase mutant vectors have been successfully tested so far for gene transfer.
A wide range of polymeric vectors have been utilized to deliver therapeutic genes in vivo.
Various viral and nonviral gene delivery vectors have been used extensively.
To address part of these questions, HIV-derived vectors have been engineered to be nonintegrating.
Alphavirus-based vectors have been engineered for in vitro and in vivo expression of heterelogous genes.
Motion vectors have been superimposed.
